SPONSOR
Universitätsklinikum Hamburg-Eppendorf
Total Trials
6
Recruiting
6
Phases
N/A
Conditions studied: Multiple Myeloma (MM)CAR T CellsBispecific AntibodiesUrethral Perfusion IndexTissue PerfusionMicrocirculationStroke, IschemicChildhood Brain TumorVital Sign MonitoringPost Operative Complications
Universitätsklinikum Hamburg-Eppendorf is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Multiple Myeloma (MM), CAR T Cells, Bispecific Antibodies, Urethral Perfusion Index.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Universitätsklinikum Hamburg-Eppendorf
How many clinical trials has Universitätsklinikum Hamburg-Eppendorf sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Universitätsklinikum Hamburg-Eppendorf, of which 6 are actively recruiting participants. These trials cover conditions including Multiple Myeloma (MM), CAR T Cells, Bispecific Antibodies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universitätsklinikum Hamburg-Eppendorf research focus on?
Universitätsklinikum Hamburg-Eppendorf clinical trials span Multiple Myeloma (MM), CAR T Cells, Bispecific Antibodies, Urethral Perfusion Index, Tissue Perfusion, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Universitätsklinikum Hamburg-Eppendorf clinical trial?
To participate in a Universitätsklinikum Hamburg-Eppendorf trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universitätsklinikum Hamburg-Eppendorf trials with current recruitment status updated daily.
Clinical Trials by Universitätsklinikum Hamburg-Eppendorf
NCT07564219
Recruiting
BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma
Multiple Myeloma (MM)
NCT06799832
Recruiting
Urethral PeRfusion Index-Guided Hemodynamic ManagemenT in Patients Having Major Abdominal Surgery: the UPRIGHT Randomized Feasibility Trial
Urethral Perfusion Index
NCT05560724
Recruiting
Network Properties As Biomarkers for Non-Invasive Brain Stimulation (NIBS) After Stroke
Stroke, Ischemic
NCT02417324
Recruiting
International HIT-MED Registry (I-HIT-MED)
Childhood Brain Tumor
NCT07385092
Recruiting
Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery
Vital Sign Monitoring
NCT03313687
Recruiting
SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK
Cardiogenic Shock
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology